2012
DOI: 10.1371/journal.pone.0046496
|View full text |Cite
|
Sign up to set email alerts
|

The Relationship between Associative Learning, Transfer Generalization, and Homocysteine Levels in Mild Cognitive Impairment

Abstract: Previous studies have shown that high total homocysteine levels are associated with Alzheimer's disease (AD) and mild cognitive impairment (MCI). In this study, we test the relationship between cognitive function and total homocysteine levels in healthy subjects (Global Dementia Rating, CDR = 0) and individuals with MCI (CDR = 0.5). We have used a cognitive task that tests learning and generalization of rules, processes that have been previously shown to rely on the integrity of the striatal and hippocampal re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 104 publications
(164 reference statements)
0
12
0
1
Order By: Relevance
“…Clinical studies have shown that eHcy is associated with the transition from being cognitively healthy to developing dementia, 27 , 28 , 29 and that eHcy is an independent risk factor for the decline of cognitive performance in normal elderly subjects and patients with Alzheimer's disease (AD). Furthermore, eHcy was found in both healthy elderly with and without MCI.…”
Section: Ehcy and Mild Cognitive Impairmentmentioning
confidence: 99%
“…Clinical studies have shown that eHcy is associated with the transition from being cognitively healthy to developing dementia, 27 , 28 , 29 and that eHcy is an independent risk factor for the decline of cognitive performance in normal elderly subjects and patients with Alzheimer's disease (AD). Furthermore, eHcy was found in both healthy elderly with and without MCI.…”
Section: Ehcy and Mild Cognitive Impairmentmentioning
confidence: 99%
“…Statistical improvement in cognitive performance was observed for individuals with no known or suspected dementia within weeks and was maintained for 1 year (the length of the study). The general beneficial effects of Nutraceutical Formulation in preclinical studies may have alleviated Alzheimer's disease-related neuropathology: for example, oxidative stress is an early event in Alzheimer's disease neuropathology, homocysteine augments Abeta-induced oxidative damage and is correlated with impaired executive function, reduced levels of glutathione potentiates neuronal oxidative damage, and reduced acetylcholine levels correlate with impaired cognitive performance [54][55][56][57]. Cognitive performance and BPSD were stabilized for individuals with severe Alzheimer's disease for 9 months beyond those receiving placebo.…”
Section: Combinatorial Formulationsmentioning
confidence: 99%
“…Plasma Hcy concentrations also increase with age (Mijatovic et al, 1998). It has been reported that HHcy is related to diseases such as coronary heart disease (Cacciapuoti 2011;Frosst et al, 1995;Humphrey et al, 2008), kidney disease (Friedman et al, 2001), Alzheimer's disease (Moustafa et al, 2012), and rheumatoid arthritis (Roubenoff et al, 1997). Hcy also induces reactive oxygen species via HADPH activation, resulting in the production of several pro-inflammatory cytokines (Fujiki et al, 2012;Lawrence et al, 2002).…”
Section: Introductionmentioning
confidence: 99%
“…Recent studies suggest that plasma Hcy concentration may be a useful biomarker of cardiovascular or neurodegenerative disease (Humphrey et al, 2008;Moustafa et al, 2012). There have been only a few investigations of plasma Hcy concentrations in dogs (Lee and Hyun, 2012;Rossi Set al, 2008;Trisolini et al, 2008).…”
Section: Introductionmentioning
confidence: 99%